Merck & Co Inc (MRK)
76.14
-0.34 -0.44%
NYSE
Dec 17, 10:26
Delayed 2m
USD
View All Key Stats
MRK Key Stats
| Income Statement | |
| Revenue (TTM) | 41.73B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 1.25 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 3.347B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 66.47% |
| Profit Margin (Quarterly) | 18.07% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 197.99B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.933 |
| PE Ratio (TTM) | 60.91 |
| Price to Book Value | 6.107 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 2.14B |
| Return on Equity (TTM) | Upgrade |
View All MRK News
MRK News
-
WireHeadlineTime (ET)
-
MT Newswires12/17 08:59
-
Yahoo12/17 08:18
-
MT Newswires12/17 07:55
-
SA Breaking News12/17 07:11
-
Business Wire12/17 06:30
-
Yahoo12/14 14:59
-
Yahoo12/14 14:59
-
Yahoo12/14 14:59
-
MT Newswires12/14 14:38
-
MT Newswires12/14 13:32
View All Events
MRK Events
| Date | Type | Description |
|---|---|---|
| 02/01/2019 08:00 EST | Misc | Merck & Co Inc Fourth Quarter Earnings Conference Call in 2018 |
| 02/01/2019 | Earnings | Merck & Co Inc Fourth Quarter Earnings in 2018 Release |
| 12/14/2018 | Dividends | Amount: 0.55, Declared Date: Oct 25 2018, Pay Date: Jan 08 2019 |
| 10/25/2018 08:00 EDT | Misc | Merck & Co Inc Third Quarter Earnings Conference Call in 2018 |
| 10/25/2018 | Earnings | Merck & Co Inc Third Quarter Earnings Results in 2018 |
| 09/14/2018 | Dividends | Amount: 0.48, Declared Date: Jul 24 2018, Pay Date: Oct 05 2018 |
| 07/27/2018 08:00 EDT | Misc | Merck & Co Inc Second Quarter Earnings Conference Call in 2018 |
| 07/27/2018 | Earnings | Merck & Co Inc Second Quarter Earnings Results in 2018 |
| 06/14/2018 | Dividends | Amount: 0.48, Declared Date: May 22 2018, Pay Date: Jul 09 2018 |
| 05/22/2018 | Misc | Merck & Co Inc Annual General Meeting in 2017 |
MRK Fundamentals
Income Statement View Statement
MRK Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
MRK One Page Reports
- One Page Report Download
MRK Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 76.14 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.merck.com
- Investor Relations URL: http://investors.merck.com/investors/default.aspx
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Value
- Next Earnings Release: Feb. 01, 2019
- Last Earnings Release: Oct. 25, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Dec. 14, 2018
- Description: Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.
MRK Excel Add-In Codes
- Name: =YCI("MRK","name")
- Description: =YCI("MRK","description")
- Sector: =YCI("MRK","sector")
- Industry: =YCI("MRK","industry")
- Est. Current Fiscal Year End: =YCI("MRK","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other MRK Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- MRK Tweets Stocktwits
Advertisement
